In vitro activity of A-56619 and A-56620 against multi-resistant and routine clinical isolates.

Abstract:

:A-56619 and A-56620 are two new quinolone compounds that are currently being studied. They were found to be active against multi-resistant and routine isolates of Staphylococcus aureus, enterobacteria, aminoglycoside-sensitive and resistant strains of Pseudomonas aeruginosa. Most of the enterobacteria were inhibited by 0.5-1 mg/l of A-56620. A-56619 was less active, concentrations of 1-4 mg/l being needed for 90% inhibition. Both the compounds were active at concentrations of 0.5-1 mg/l against staphylococci, including multi-resistant S. aureus. The MIC90 for P. aeruginosa was 1-2 mg/l for A-56620 and 8 mg/l for A-56619.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Fernandes CJ,Wilson RD,Ackerman VP

doi

10.1159/000238573

subject

Has Abstract

pub_date

1988-01-01 00:00:00

pages

216-28

issue

3

eissn

0009-3157

issn

1421-9794

journal_volume

34

pub_type

杂志文章
  • A dose escalation trial of biweekly docetaxel and gemcitabine with filgrastim or pegfilgrastim for the treatment of patients with advanced solid tumors.

    abstract:BACKGROUND/AIMS:A single-institution phase I trial to determine the feasibility of using filgrastim or pegfilgrastim to increase the dose intensity of biweekly docetaxel and gemcitabine. METHODS:Patients with metastatic solid tumors received gemcitabine 3,000 mg/m(2) and increasing doses of docetaxel (55 mg/m(2) in 10...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000313526

    authors: Dragnev KH,Hardin SB,Pipas JM,Davis TH,Rigas JR

    更新日期:2010-01-01 00:00:00

  • Derivation of meropenem dosage in patients receiving continuous veno-venous hemofiltration based on pharmacodynamic target attainment.

    abstract:BACKGROUND:Dosage recommendations for antibiotics in patients receiving continuous veno-venous hemofiltration (CVVH) should be based on pharmacodynamic requirements. For meropenem, this would be achieving appropriate time above the minimum inhibitory concentration (T > MIC). We employed Monte Carlo simulation to calcul...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000086598

    authors: Kuti JL,Nicolau DP

    更新日期:2005-07-01 00:00:00

  • Bacteraemia by P. aeruginosa associated with nephrotic syndrome after shunt operation for hydrocephalus.

    abstract::One patient of sepsis by P. aeruginosa after the implanting of a ventriculoatrial valve following extirpation of an expansive intracranial process is studied. During the evolution of the septic process there appeared as associated nephrotic syndrome with histologic lesions corresponding to an acute exudative glomerula...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222085

    authors: Rodriguéz-Gironés M,Genovés A

    更新日期:1977-01-01 00:00:00

  • Variable sensitivity of lymphoblastoid cells to apoptosis induced by Viscum album Qu FrF, a therapeutic preparation of mistletoe lectin.

    abstract:BACKGROUND:Viscum album (VA) Qu FrF preparation consists of an aqueous extract of Viscum album, the European mistletoe. It has cytotoxic and immunomodulatory properties that support its usefulness in cancer therapy. However, only little information is available on the interaction between mistletoe lectin (ML) and the h...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048545

    authors: Duong Van Huyen JP,Sooryanarayana,Delignat S,Bloch MF,Kazatchkine MD,Kaveri SV

    更新日期:2001-09-01 00:00:00

  • Ofloxacin, a bactericidal antibacterial.

    abstract::Ofloxacin, like other 4-quinolones, is unusual among front line drugs available to treat bacterial infections since it affects bacterial DNA synthesis, rather than cell wall or protein synthesis. The 4-quinolones are also unusual because even for serious infections they can be given orally. Most unusually transferable...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000238899

    authors: Smith JT

    更新日期:1991-01-01 00:00:00

  • Influence of human serum on bactericidal activity of ceftizoxime sodium.

    abstract::The influence of normal human serum on bactericidal activity of ceftizoxime sodium (CZX) was studied in vitro against Escherichia coli and Staphylococcus aureus. Subminimal inhibitory concentrations of CZX inhibited the growth of bacteria. Normal human serum as a source of complement and low doses of CZX, such as 1/20...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238399

    authors: Watanabe K,Kin R,Murakami M,Kondo M

    更新日期:1986-01-01 00:00:00

  • Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.

    abstract::The introduction of highly active antiretroviral therapy (HAART) has significantly modified the course of human immunodeficiency virus (HIV) disease, with longer survival and improved quality of life of HIV-infected subjects. However, HAART regimens, especially those including protease inhibitors, have been shown to c...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000093034

    authors: Barbaro G,Barbarini G

    更新日期:2006-01-01 00:00:00

  • A 13-year study of antimicrobial susceptibility of common gram-negative bacteria isolated from the bloodstream in a teaching hospital.

    abstract::The choice of antimicrobial therapy for the treatment of bacteremia is often empirical and based on the knowledge of susceptibility profiles of the most common bacteria. We analyzed blood culture isolates from a teaching hospital for 13 years prospectively. This study examined the susceptibility profiles of 6,616 gram...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048498

    authors: Ling TK,Liu EY,Cheng AF

    更新日期:2001-01-01 00:00:00

  • Immunotoxicity of cephalosporins in mice.

    abstract::This study was performed in female B6C3F1 mice to confirm previously observed effects of selected cephalosporin antibiotics on nonspecific immunity, and to determine possible effects on specific acquired immunity and host resistance. Mice were treated intravenously with DQ-2556, ceftizoxime or ceftezole at 800 mg/kg/d...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239137

    authors: Furuhama K,Benson RW,Knowles BJ,Roberts DW

    更新日期:1993-07-01 00:00:00

  • Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.

    abstract::The in vitro activities of the newer agents Deptomycin, Difloxacin, A-56620 and Ciprofloxacin were compared with those of vancomycin, rifampin and gentamicin against methicillin-susceptible and -resistant Staphylococcus aureus and coagulase-negative staphylococci. All isolates were susceptible to vancomycin, rifampin,...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238691

    authors: Chandrasekar PH,Sluchak JA

    更新日期:1989-01-01 00:00:00

  • Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.

    abstract::The activities of amphotericin B, miconazole, fluconazole, and itraconazole against Trichosporon beigelii were assessed in a mouse model of disseminated infection. Cyclophosphamide plus prednisolone-immunosuppressed ICR mice, intravenously challenged with a lethal inoculum of (6 x 10(6) CFU/ mouse), were assigned to r...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007091

    authors: Kamberi P,Atsuro H,Takayoshi T,Masaru N

    更新日期:1998-01-01 00:00:00

  • 5-Fluorocytosine kinetics in patients with acute renal failure undergoing continuous hemofiltration.

    abstract::The pharmacokinetic disposition of 5-fluorocytosine (5-FC) was studied in 7 patients with acute renal failure undergoing continuous hemofiltration (CH). CH was performed with a high-flux membrane and the average filtration rate (FR) was 16.3 ml/min. Following an intravenous loading dose of 2,500 mg, 5-FC concentration...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238478

    authors: Ittel TH,Legler UF,Polak A,Glöckner WM,Sieberth HG

    更新日期:1987-01-01 00:00:00

  • In vitro interactions of amikacin and beta-lactam antibiotics against amikacin-resistant gram-negative bacilli.

    abstract::We tested 42 strains of amikacin-resistant gram-negative bacilli with amikacin in combination with six beta-lactam antibiotics using the checkerboard and time-kill curve techniques. Synergism was demonstrated with time-killing curve in 43-68% of the strains tested. Ceftazidime plus amikacin was the most active combina...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238556

    authors: Alvarez S,Jones M,Holtsclaw-Berk S,Berk SL

    更新日期:1988-01-01 00:00:00

  • In vitro and in vivo studies of the action of rifampicin, clofazimine and B1912 on Mycobacterium marinum.

    abstract::Rifampicin (RMP) and two riminophenazine compounds (B663 and B1912) suppressed the growth of Mycobacterium marinum in vitro and in a mouse footpad infection. At appropriate concentrations and dietary dosage, all three drugs showed bactericidal activity in vitro and in vivo. On the basis of minimum inhibitory concentra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221931

    authors: Banerjee DK,Holmes IB

    更新日期:1976-01-01 00:00:00

  • In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.

    abstract::The in vitro activity of cefetamet against Escherichia coli, Klebsiella pneumoniae and Serratia marcescens strains expressing an SHV-5-type beta-lactamase was evaluated. Most of the examined strains were susceptible to the antibiotic. Cefetamet was found to be considerably more active than ceftazidime and aztreonam. I...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239462

    authors: Tzouvelekis LS,Prinarakis EE,Gazouli M,Miriagou V,Tzelepi E,Legakis NJ

    更新日期:1996-09-01 00:00:00

  • Urinary pharmacokinetics and bactericidal activity of finafloxacin (200 and 800 mg) in healthy volunteers receiving a single oral dose.

    abstract:BACKGROUND:Finafloxacin is a novel 8-cyano-fluoroquinolone under investigation for treatment of urinary tract infection. METHODS:Urinary concentrations and urinary bactericidal titers (UBT) of finafloxacin 200- and 800-mg single doses in 6 healthy volunteers were measured up to 48 h. UBT were determined for a referenc...

    journal_title:Chemotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000321028

    authors: Wagenlehner FM,Wagenlehner CM,Blenk B,Blenk H,Schubert S,Dalhoff A,Naber KG

    更新日期:2011-01-01 00:00:00

  • Treatment of experimental chronic osteomyelitis caused by Morganella morganii with mezlocillin and cloxacillin.

    abstract::Mezlocillin was used alone and in combination with cloxacillin in the treatment of chronic experimental osteomyelitis due to Morganella morganii. This combination showed in vitro synergy as measured by the checkerboard technique. A marked inoculum affect was demonstrated in vitro with mezlocillin and the infecting str...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238267

    authors: Norden CW,Shaffer M

    更新日期:1984-01-01 00:00:00

  • The clinical use of aztreonam.

    abstract::Aztreonam is the first monobactam antibiotic to be used clinically. It is highly resistant to beta-lactamases, and although its activity spectrum is similar to that of the aminoglycoside antibiotics, it has no effect on gram-positive bacteria. The current study was undertaken to determine the efficacy of aztreonam in ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238720

    authors: Schönwald S,Schoss-Vidensek Z,Car V,Krznar B

    更新日期:1989-01-01 00:00:00

  • In vitro activities of erythromycin, tetracycline and levofloxacin alone and in dual combinations against ureaplasma spp.

    abstract:PURPOSE:It was the aim of our study to evaluate the in vitro activities of tetracycline (TET), erythromycin (ERY) and levofloxacin (LVX) alone and in dual combinations against ureaplasmas. METHODS:The minimum inhibitory concentrations (MICs) of 51 ureaplasmal strains were determined by microdilution assay. RESULTS:TE...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000323629

    authors: Luo DQ,Liu JY,Yang W,Zhang B,Yu MJ,Wu YM

    更新日期:2011-01-01 00:00:00

  • Effects of platinum antitumor agents on in vitro assays of human antitumor immunity. II. Effects of cis-[Pt(NH3)2Cl2] on spontaneous cell-mediated cytotoxicity.

    abstract::The effects of cis-[Pt(NH3)2Cl2] on the spontaneous cell-mediated cytotoxicity of human lymphoblast cell lines mediated by normal human peripheral blood lymphocytes was investigated. Direct addition of cis-[Pt(NH3)2Cl2], but not its tumor inactive trans isomer, to the in vitro spontaneous cytotoxicity assay resulted i...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237876

    authors: Mally MB,Taylor RC,Callewaert DM

    更新日期:1980-01-01 00:00:00

  • Antineoplastic strategy: irreversible tumor blood flow stasis induced by the combretastatin A-4 derivative AVE8062 (AC7700).

    abstract::Despite extensive research efforts, effective therapies for refractive cancers have not yet been established, and development of successful treatment strategies remains the most important task in the field of oncology. We recently showed that AVE8062 (formerly AC7700), a derivative of combretastatin A-4, achieved irre...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000088961

    authors: Hori K

    更新日期:2005-10-01 00:00:00

  • In vitro antibacterial activity of men 10700, a new penem antibiotic.

    abstract::We report here the antibacterial activity of the new penem antibiotic Men 10700 against a total of 740 gram-positive and gram-negative clinical isolates, in comparison to imipenem, meropenem, cefotaxime, ceftriaxone, ciprofloxacin and gentamicin. Men 10700 has shown a wide spectrum of antibacterial activity, with a po...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007233

    authors: Varotto F,Parravidini E,De Luca M,Casini A,Fraschini F

    更新日期:1999-11-01 00:00:00

  • Pharmacokinetics of fosfomycin.

    abstract::Fosfomycin, an antibiotic discovered in Spain, has a unique chemical structure and pharmacologic features that are promising for clinical therapy. It is only partially absorbed orally, with relatively low blood levels. Intramuscularly, however, absorption is complete with peak blood levels 3-5 times as high as orally,...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222040

    authors: Kirby WM

    更新日期:1977-01-01 00:00:00

  • Pneumococcal meningitis-therapeutic studies in mice.

    abstract::A technique for inducing pneumococcal meningitis in mice and a description of the histopathologic changes that accompany this experimentally produced disease are provided in the present report. This infection of mice was investigated to determine whether it could serve as a suitable model for detecting agents that hav...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221879

    authors: Tsai YH,Williams EB,Hirth RS,Price KE

    更新日期:1975-01-01 00:00:00

  • Artemisinin (qinghaosu)--a new gametocytocidal drug for malaria.

    abstract::Gametocytocidal activity of artemisinin (qinghaosu) has been demonstrated against simian malaria parasite Plasmodium cynomolgi B. Colony-bred Anopheles stephensi were allowed to feed on gametocyte-carrying rhesus monkeys and the mosquito infectivity rate and oocyst count of the infected mosquito gut were recorded on d...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238671

    authors: Dutta GP,Bajpai R,Vishwakarma RA

    更新日期:1989-01-01 00:00:00

  • Simple combined agar-strip test for detection of enterococcal susceptibility to ampicillin, moderate- or high-level gentamicin resistance and potential additive activity of ampicillin plus gentamicin.

    abstract::A simple combined agar-strip test (CAST), involving filter paper strips charged with 20 micrograms of ampicillin or 40 micrograms of gentamicin, accurately detected high-level gentamicin resistance among 43 of 146 isolates of Enterococcus faecalis and additive activity of ampicillin plus gentamicin against 101 of 103 ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239107

    authors: Traub WH,Leonhard B

    更新日期:1993-03-01 00:00:00

  • Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.

    abstract:BACKGROUND:Mutant prevention concentration (MPC) is a new parameter that may be of aid in determining the risk of resistant mutants being selected. METHODS:The MPCs of 224 Mycobacterium tuberculosis clinical isolates were estimated by plating more than 10(10) cells on drug-containing agar and determining the concentra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000085613

    authors: Rodríguez JC,Cebrián L,Ruiz M,López M,Royo G

    更新日期:2005-05-01 00:00:00

  • In vitro activity of BMY-28142, a new cephalosporin.

    abstract::BMY-28142 was compared in vitro with ceftazidime, cefotaxime and cefoperazone and was found to be more active against Pseudomonas aeruginosa and Staphylococcus aureus. Essentially no effect of increasing inoculum size 100-fold was seen-on MICs with BMY-28142 or ceftazidime; some effect was noted with cefotaxime and ce...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238470

    authors: Norden CW,Neiderriter K

    更新日期:1987-01-01 00:00:00

  • The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factors.

    abstract:BACKGROUND:We evaluated the effectiveness of docetaxel or erlotinib in second-line treatment of non-small cell lung cancer (NSCLC) and focused on the impact of predictive factors on the outcome of therapy. METHODS:204 patients with progressive disease after platinum-based therapy were enrolled: 102 received an infusio...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000336143

    authors: Krawczyk P,Kowalski DM,Wojas-Krawczyk K,Mlak R,Jaśkiewicz P,Kucharczyk T,Winiarczyk K,Krzakowski M,Milanowski J

    更新日期:2012-01-01 00:00:00

  • Hepatic arterial infusion with irinotecan in patients with liver metastases of colorectal cancer: results of an extended phase I study.

    abstract:BACKGROUND:To define the maximum tolerated dose (MTD) tolerability and efficacy of intra-arterial chemotherapy with irinotecan in patients with liver metastases of colorectal carcinoma (CRC). METHODS:Superselective intra-arterial irinotecan was applied on days 1, 14, 28 and 42. The initial dose was 140 mg/m² with esca...

    journal_title:Chemotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000348579

    authors: Eichler K,Dufas T,Hammerstingl R,Gruber-Rouh T,Vogl TJ,Zangos S

    更新日期:2013-01-01 00:00:00